Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 119

Results For "Experience"

1584 News Found

Lonza to sell processing plant in Quakertown, Pennsylvania
News | May 08, 2022

Lonza to sell processing plant in Quakertown, Pennsylvania

Upon closing, the Quakertown business will become an independent company called Microsize


Thieme EIDO Healthcare launches digital consent platform with Indian Medical Association
Digitisation | May 06, 2022

Thieme EIDO Healthcare launches digital consent platform with Indian Medical Association

The aim is to bring patient consent tools in a digital format in addition to a paper format which is not just a need of the current times but also a way forward


ACG appoints Udit K Singh as CEO of its Inspection division
People | May 06, 2022

ACG appoints Udit K Singh as CEO of its Inspection division

He will be responsible for ensuring that every dose of medication that ACG Inspection’s pharmaceutical and nutraceutical partners provide is manufactured and delivered exactly as intended


Mediso acquires nuclear medicine supplier Bartec Technologies
Biotech | May 05, 2022

Mediso acquires nuclear medicine supplier Bartec Technologies

In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership


World’s first AI software for detecting pancreatic disease on the horizon
Biotech | May 02, 2022

World’s first AI software for detecting pancreatic disease on the horizon

As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies


StanPlus appoints Gurjit Singh as COO and Founding Member
People | May 02, 2022

StanPlus appoints Gurjit Singh as COO and Founding Member

He will be leading the business, operations, P&L, and growth strategy for StanPlus


Camzyos is the first and only USFDA-approved cardiac myosin inhibitor
Biotech | April 29, 2022

Camzyos is the first and only USFDA-approved cardiac myosin inhibitor

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo


Ayu Health raises US $ 27 million in series B round
Startup | April 28, 2022

Ayu Health raises US $ 27 million in series B round

The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital


Thalassemia and Sickle Cell Society (TSCS) to organise national conference
Public Health | April 28, 2022

Thalassemia and Sickle Cell Society (TSCS) to organise national conference

TSCS appeals to the Govt. of Telangana to release a G.O for mandatory antenatal test - HbA2 for every pregnant woman to help prevent the birth of Thalassemia Major Children for the well-being of their family & Telangana State


Wipro GE Healthcare launches locally made CT system
Healthcare | April 28, 2022

Wipro GE Healthcare launches locally made CT system

Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme